Paper41170366
Development and preliminary mechanistic analysis of compound effervescent hepatoprotective granules.
Liu X and 12 others. Front Nutr, 2025. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Development and preliminary mechanistic analysis of compound effervescent hepatoprotective granules. Papers, record 41170366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41170366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development and preliminary mechanistic analysis of compound effervescent hepatoprotective granules.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 27322403 | The GeneCards Suite: From Gene Data Mining to Disease Genome Sequence Analyses. | Curr Protoc Bioinformatics | 2016 | https://conductscience.org/library/papers/27322403 | PubMed |
| 2 | 40113123 | Hypoxia-inducible factor-1 alpha (HIF-1α) inhibitor AMSP-30 m attenuates CCl4-induced liver fibrosis in mice by inhibiting the sonic hedgehog pathway. | Chem Biol Interact | 2025 | https://conductscience.org/library/papers/40113123 | PubMed |
| 3 | 40017143 | Underlying mechanisms and treatment of acetaminophen‑induced liver injury (Review). | Mol Med Rep | 2025 | https://conductscience.org/library/papers/40017143 | PubMed |
| 4 | 20430828 | PharmMapper server: a web server for potential drug target identification using pharmacophore mapping approach. | Nucleic Acids Res | 2010 | https://conductscience.org/library/papers/20430828 | PubMed |
| 5 | 35499001 | Structural characterization and hepatoprotective activity of an acidic polysaccharide from Ganoderma lucidum. | Food Chem X | 2022 | https://conductscience.org/library/papers/35499001 | PubMed |
| 6 | 40052151 | Involvement of SIRT1-mediated aging in liver diseases. | Front Cell Dev Biol | 2025 | https://conductscience.org/library/papers/40052151 | PubMed |
| 7 | 35543349 | Ganoderic acid A from Ganoderma lucidum protects against alcoholic liver injury through ameliorating the lipid metabolism and modulating the intestinal microbial composition. | Food Funct | 2022 | https://conductscience.org/library/papers/35543349 | PubMed |
| 8 | 40052242 | Chelerythrine-mediated targeting of NF-κB and Nrf2 pathways alleviates liver injury in a carbon tetrachloride-induced liver fibrosis mouse model. | Histol Histopathol | 2025 | https://conductscience.org/library/papers/40052242 | PubMed |
| 9 | 40257700 | GNF-5837 attenuates acute liver injury by inhibiting oxidative stress. | Mol Biol Rep | 2025 | https://conductscience.org/library/papers/40257700 | PubMed |
| 10 | 37999259 | Metabolomic Insights into the Mechanisms of Ganoderic Acid: Protection against α-Amanitin-Induced Liver Injury. | Metabolites | 2023 | https://conductscience.org/library/papers/37999259 | PubMed |
| 11 | 36510282 | Application of Box-Behnken experimental design and response surface methodology for selecting the optimum RP-HPLC conditions for the simultaneous determination of methocarbamol, indomethacin and betamethasone in their pharmaceutical dosage form. | BMC Chem | 2022 | https://conductscience.org/library/papers/36510282 | PubMed |
| 12 | 40051561 | Thonningianin A ameliorates acetaminophen-induced liver injury by activating GPX4 and modulating endoplasmic reticulum stress. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40051561 | PubMed |
| 13 | 39756831 | The Traditional Applications, Phytochemistry, Pharmacology, Pharmacokinetics, Quality Control and Safety of Paeoniae Radix Alba: A Review. | Am J Chin Med | 2024 | https://conductscience.org/library/papers/39756831 | PubMed |
| 14 | 35126604 | The Potential Hepatoprotective Effect of Paeoniae Radix Alba in Thioacetamide-Induced Acute Liver Injury in Rats. | Evid Based Complement Alternat Med | 2022 | https://conductscience.org/library/papers/35126604 | PubMed |
| 15 | 34028092 | The p53/p21/p16 and PI3K/Akt signaling pathways are involved in the ameliorative effects of maltol on D-galactose-induced liver and kidney aging and injury. | Phytother Res | 2021 | https://conductscience.org/library/papers/34028092 | PubMed |
| 16 | 38067630 | Natural Products for Acetaminophen-Induced Acute Liver Injury: A Review. | Molecules | 2023 | https://conductscience.org/library/papers/38067630 | PubMed |
| 17 | 36858276 | Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. | J Ethnopharmacol | 2023 | https://conductscience.org/library/papers/36858276 | PubMed |
| 18 | 19131956 | Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. | Nat Protoc | 2009 | https://conductscience.org/library/papers/19131956 | PubMed |
| 19 | 38537438 | Integrated serum pharmacochemistry and network pharmacology to explore the mechanism of Yi-Shan-Hong formula in alleviating chronic liver injury. | Phytomedicine | 2024 | https://conductscience.org/library/papers/38537438 | PubMed |
| 20 | 39461197 | Chidan Tuihuang granule modulates gut microbiota to influence NOD1/RIPK2 pathway in cholestatic liver injury recovery. | Phytomedicine | 2024 | https://conductscience.org/library/papers/39461197 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41170366
GET https://conductscience.org/api/papers/v1/41170366/references?page=2